International Clinical Trial: A Single-Arm, Single-Center, Prospective Clinical Trial of Regorafenib Combined with Serplulimab and Stereotactic Radiotherapy as Third-Line Treatment for Metastatic Colorectal Cancer

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115572) titled 'A Single-Arm, Single-Center, Prospective Clinical Trial of Regorafenib Combined with Serplulimab and Stereotactic Radiotherapy as Third-Line Treatment for Metastatic Colorectal Cancer' on Dec. 29, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Sichuan Cancer Hospital

Condition: Primary colon cancer or primary rectal cancer.

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2025-12-31

Target Sample Size: Treatment Group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=302420

Published by HT Dig...